This study was undertaken to investigate whether progranulin sustains STAT3 hyper‐activation in CRC and whether its inhibition may represent a feasible approach to restrain STAT3 oncogenic function in such neoplasia. This evidence concerns the gene STAT3 and colorectal carcinoma.